NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of MGP Ingredients, Inc. (NASDAQ: MGPI). Shareholders who purchased shares of MGPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI). Shareholders who purchased shares of KSPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nextracker Inc. (NASDAQ: NXT). Shareholders who purchased shares of NXT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Shareholders who purchased shares of REGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU). Shareholders who purchased shares of CRBU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Micron Technology, Inc. (NASDAQ: MU). Shareholders who purchased shares of MU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Many Wall Street analysts think the S&P 500 will rise for the third consecutive year in 2025. Projections vary, but the consensus forecast appears to be that the index could jump in the ballpark of 10%.

Akebia Therapeutics is currently shifting focus from Auryxia to Vafseo due to Auryxia's declining revenues from patent expiration. Vafseo is now approved for dialysis patients and leverages AKBA's signature HIF pathway. So far, it has shown some early successes, which makes me optimistic. AKBA is also working on a Phase 3 trial for non‑dialysis CKD patients, which is scheduled for mid‑2025 to support a potential label expansion.

Delinquency rate growth is continuing to slow, creating a positive operating environment for SoFi. Refinancing demand exists, and SoFi is ready to capture the demand through its continued member growth and flywheel strategy. Despite about 100% stock price appreciation in recent months, I continue to believe that the company is reasonably valued.

Popular market analyst Tom Lee of Fundstrat recently called the financial sector his favorite investment for 2025.

Trump's 25% steel and aluminum tariffs rattle markets, fueling inflation fears and currency swings. Traders brace for volatility as the Fed weighs its next move.

SHANGRAO, China , Feb. 10, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it ranked No.1 in the Global Solar Module Manufacturers Ranking 2025 report recently published by Wood Mackenzie, thanks to its outstanding technological capabilities and highly efficient module performance.

BP shares surged on Monday, rising nearly 7% in early trading, after reports emerged that activist hedge fund Elliott Investment Management had acquired a stake in the British oil giant. The size of Elliott's holding has not been disclosed, but its involvement is already fuelling speculation about potential changes to BP's strategy and leadership.

Taco Bell's strong performance in FY 2024, driven by same-store sales and innovation, contrasts with KFC's struggles in the U.S. but gains internationally. Pizza Hut remains the underdog in the 'Battle of Pizzas,' with weak same-store sales and top-line growth, but easier comparisons ahead. Valuation models suggest Yum! Brands is fairly valued; without significant improvement in KFC's U.S. performance, the stock is unlikely to soar.

Alibaba stock price remains in a three-year consolidation. It has remained between the support and resistance levels at $56.50 and $121.37 since 2022 even as its biggest competitors in China like JD.com and Tencent have surged.

You might not realize it, but this could arguably be described as the most important week of data on Wall Street for the first quarter -- and this has nothing to do with the steady stream of operating results being announced by the stock market's most-influential businesses.